ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

HILLARY HOTELLING MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 761

$0 Total Retail Price of All Prescriptions

Rank: 761 out of 761

198 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 198 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

19% of this provider’s 198 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 7,744 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 448 405 1 2
OMEPRAZOLE 412 357 2 4
CITALOPRAM HBR 307 257 3 19
GABAPENTIN 301 301 4 15
FUROSEMIDE 277 234 5 7
LEVOTHROID 265 241 6 44
LISINOPRIL 256 222 7 1
OXYCODONE HCL 248 209 S2 8 24
WARFARIN SODIUM 183 178 9 9
KLOR-CON 10 183 156 9 74
LOSARTAN POTASSIUM 181 162 11 13
SYNTHROID 164 143 12 64
POLYETHYLENE GLYCOL 3350 164 150 12 62
HYDROCODONE-ACETAMINOPHEN 163 154 S3 14 5
ENALAPRIL MALEATE 161 144 15 71
TRAZODONE HCL 160 124 16 23
HYDROCHLOROTHIAZIDE 158 127 17 11
AMLODIPINE BESYLATE 153 114 18 6
METOPROLOL SUCCINATE 145 140 19 16
METFORMIN HCL 139 84 20 10
CARVEDILOL 139 124 20 26
SERTRALINE HCL 132 132 22 25
METOPROLOL TARTRATE 125 117 23 14
ATENOLOL 121 110 24 8
LOVASTATIN 116 103 25 17
DONEPEZIL HCL 106 106 26 33
NAMENDA 93 93 27 59
ALENDRONATE SODIUM 91 82 28 21
AGGRENOX 89 89 29 121
RISPERIDONE 89 69 29 83
MIRTAZAPINE 87 75 31 50
POTASSIUM CHLORIDE 77 77 32 18
DIVALPROEX SODIUM 67 37 33 97
TRAMADOL HCL 64 58 34 34
PAROXETINE HCL 63 61 35 47
ONDANSETRON HCL 61 61 36 230
ISOSORBIDE MONONITRATE ER 60 49 37 72
ZOLPIDEM TARTRATE 59 55 38 22
TAMSULOSIN HCL 56 56 39 27
GLIPIZIDE 53 41 40 39
FLUTICASONE PROPIONATE 53 46 40 29
LANTUS 52 20 42 41
CLOZAPINE 52 40 42 338
PREDNISONE 51 50 44 30
OLANZAPINE 50 50 45 144
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.